Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 7, 2023
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid LeukemiaSeda Baykal-Köse, Maud Voldoire, Christophe Desterke, et al.
Oncogene|March 1, 2005
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitroValérie Soenen-Cornu, Cristina Tourino, Marie-Laure Bonnet, et al.
European Journal of Immunology|May 16, 2012
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patientsAlexis Rossignol, Anaïs Levescot, Florence Jacomet, et al.
International Journal of Cancer|May 18, 2010
STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?Claire Villalva, Severine Martin-Lannerée, Ulrich Cortes, et al.
Experimental Hematology|January 5, 2013
Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis modelMichael Melkus, Annelise Bennaceur-Griscelli, Yannick Valogne, et al.
International Journal of Molecular Sciences|October 28, 2023
Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast CrisisLara Boucher, Nathalie Sorel, Christophe Desterke, et al.
Stem Cell Research|December 4, 2017
Transcriptional landscape of a RETC634Y-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancersJulien Hadoux, Christophe Desterke, Olivier Féraud, et al.
Experimental Hematology|March 23, 2010
Tyrosine phosphorylation of SHIP promotes its proteasomal degradationJens Ruschmann, Victor Ho, Frann Antignano, et al.
Frontiers in Immunology|January 23, 2024
Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis modelJusuf Imeri, Paul Marcoux, Matthias Huyghe, et al.
Biochemical and Biophysical Research Communications|July 31, 2018
Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopyChristophe Sandt, Olivier Feraud, Marie-Laure Bonnet, et al.
Pageof 9